{
    "clinical_study": {
        "@rank": "104094", 
        "arm_group": {
            "arm_group_label": "Diagnostic (modified barium swallow)", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergo the modified barium swallow, comprising swallowing boluses of thin liquid barium, barium honey, barium pudding, and barium crackers while undergoing fluoroscopic imaging."
        }, 
        "brief_summary": {
            "textblock": "This pilot clinical trial studies the modified barium swallow in measuring swallowing\n      function after surgery in patients with oropharyngeal cancer who have undergone surgery. New\n      diagnostic procedures, such as the modified barium swallow, may be effective in studying the\n      side effects of cancer therapy in patients who received treatment for oropharyngeal cancer"
        }, 
        "brief_title": "Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer", 
        "condition": "Oropharyngeal Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Head and Neck Neoplasms", 
                "Oropharyngeal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To compare aspiration in oropharyngeal carcinoma patients that underwent transoral\n      robotic surgery (TORS) vs. chemoradiotherapy (CRT) via an objective instrument, the modified\n      barium swallow (MBS).\n\n      SECONDARY OBJECTIVES:\n\n      I. To compare patient-perceived swallowing function of oropharyngeal carcinoma patients that\n      underwent TORS vs. CRT via a subjective instrument, the M.D. Anderson Dysphagia Inventory\n      (MDADI) using the total MDADI score.\n\n      II. To compare patient-perceived swallowing function of oropharyngeal carcinoma patients\n      that underwent TORS vs. CRT via a second subjective instrument, the Eating Assessment Tool\n      (EAT-10) using the total EAT-10 score.\n\n      III. To estimate the correlation between the maximum Penetration Aspiration Scale (PAS)\n      score and MDADI total score in TORS or CRT oropharyngeal carcinoma patients regardless of\n      treatment modality.\n\n      IV. To estimate the correlation between the maximum PAS score and EAT-10 total score in TORS\n      or CRT oropharyngeal carcinoma patients regardless of treatment modality.\n\n      V. To estimate the correlation between MDADI total score and EAT-10 total score in TORS or\n      CRT oropharyngeal carcinoma patients regardless of treatment modality.\n\n      VI. To estimate cervical esophageal stricture diameters after TORS vs. CRT via an objective\n      instrument, the MBS.\n\n      OUTLINE:\n\n      Patients undergo the modified barium swallow, comprising swallowing boluses of thin liquid\n      barium, barium honey, barium pudding, and barium crackers while undergoing fluoroscopic\n      imaging."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient must have undergone TORS or CRT for oropharyngeal carcinoma 6-24 months prior\n             at Wake Forest University Baptist Hospital (WFUBH)\n\n          -  In CRT treated participants, CRT had to be delivered as a primary modality with\n             curative intent\n\n          -  In TORS treated participants, TORS had to be done as a primary modality with curative\n             intent\n\n          -  Written informed consent\n\n          -  No evidence of recurrent disease or second primary tumors on physical examination\n\n        Exclusion Criteria:\n\n          -  Previous head and neck surgery, radiation, or chemotherapy preceding TORS\n\n          -  Previous head and neck surgery preceding CRT\n\n          -  If CRT patient, candidacy for TORS is not met\n\n          -  Known neurologic dysfunction affecting swallowing\n\n          -  Evidence of recurrent or second primary cancers on examination\n\n          -  Patient pregnancy (due to radiation exposure risk to unborn fetus)\n\n          -  Inability to grant informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "89 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01767961", 
            "org_study_id": "CCCWFU 97312", 
            "secondary_id": [
                "NCI-2012-02165", 
                "P30CA012197"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Diagnostic (modified barium swallow)", 
                "description": "Undergo MBS", 
                "intervention_name": "diagnostic imaging", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Diagnostic (modified barium swallow)", 
                "description": "Correlative studies", 
                "intervention_name": "questionnaire administration", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Diagnostic (modified barium swallow)", 
                "description": "Correlative studies", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": "quality of life assessment"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 28, 2014", 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study Assessing Swallowing Function After Transoral Robotic Surgery (TORS) for Head and Neck Cancer", 
        "overall_official": {
            "affiliation": "Comprehensive Cancer Center of Wake Forest University", 
            "last_name": "Joshua Waltonen", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The maximum PAS score will be dichotomized into aspiration vs no aspiration. The highest (closest to 8 on the PAS scale) PAS score of the 10 swallows will be used for dichotomization. A PAS score of 6 or greater indicates aspiration, while a PAS score of 5 or less is indicative of no aspiration. McNemar's test for correlated proportions will be used to assess the difference between the two treatment groups.", 
            "measure": "Dichotomized aspiration, measured via the maximum Penetration-Aspiration Scale (PAS) delineated from the MBS", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01767961"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The total MDADI score will be analyzed using paired t-tests.", 
                "measure": "Swallowing function, assessed by the MDADI score", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "The total EAT-10 score will be analyzed using paired t-tests.", 
                "measure": "Perceived subjective swallowing function, assessed using the EAT-10", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "A paired t-test will be used to assess the difference in cervical esophageal stricture diameters between the two treatment groups.", 
                "measure": "Cervical esophageal stricture measurements", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }
        ], 
        "source": "Comprehensive Cancer Center of Wake Forest University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Comprehensive Cancer Center of Wake Forest University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014", 
        "why_stopped": "Unable to secure funding."
    }
}